news aktuell GmbHnews aktuell GmbH

IFCO appoints Iñigo Canalejo as Vice President, ESG

Share
Mr. Canalejo joins IFCO to further build on its intrinsically sustainable business model and to ensure delivering against the company’s ambitious ESG strategy

(Munich, Germany): IFCO, the world’s leading provider of Reusable Plastic Containers (RPCs) for fresh food packaging, appoints Iñigo Canalejo as Vice President, ESG (Environmental, Social & Governance) as of August 1st. IFCO is strongly committed to its ESG strategy and to making the world’s fresh grocery supply chain sustainable.

IFCO´s business model is built on the principles of the circular economy with a strong focus on sustainability and has recently had its European line of Lift Lock RPCs awarded Cradle to Cradle Certified® at the Silver level. By leveraging the environmental benefits of its business model, where RPCs are being re-used up to 120 times, washed, sanitized and then at the end of their life cycle, granulated in order to produce new crates, IFCO enables significant CO2, water and energy savings as well as reductions in solid and food waste when compared to single-use packaging.

“Over the past years we have achieved great progress in delivering against our sustainability agenda with one highlight being Cradle to Cradle Certified® at the Silver level. This reinforces our leading role in the industry, successfully applying the model of the circular economy for many years”, says Michael Pooley, CEO at IFCO. “I am delighted to welcome Iñigo Canalejo in our team. He brings many years of experience in successfully leading ESG programs in the industry and will help us to position IFCO at the forefront of supply chain sustainability.”

Please find the full text as well as images here: https://bit.ly/3rAPGRw

Contacts

Agency contact:
HBI Helga Bailey GmbH
Corinna Voss
Tel.: +49 89 99388730
ifco@hbi.de

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release

Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized

Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:12:30 CET | Press release

youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye